{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:51:12Z","timestamp":1790351472421,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Tuscany Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.critrevonc.2025.105090","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T23:03:49Z","timestamp":1765753429000},"page":"105090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role of the bone marrow microenvironment in leukemic stem cell resistance: Pathways of persistence and selection"],"prefix":"10.1016","volume":"218","author":[{"given":"Serena","family":"Barachini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Montali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Sofia","family":"Burzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella Sardo","family":"Infirri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella Cassano","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.critrevonc.2025.105090_bib1","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1038\/s41388-019-0741-6","article-title":"Connexins in cancer: bridging the gap to the clinic","volume":"38","author":"Aasen","year":"2019","journal-title":"Oncogene"},{"issue":"7571","key":"10.1016\/j.critrevonc.2025.105090_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature15250","article-title":"Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal","volume":"526","author":"Acar","year":"2015","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.105090_bib3","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood-2011-05-355396","article-title":"Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML","volume":"120","author":"Agarwal","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.stem.2019.02.018","article-title":"Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells","volume":"24","author":"Agarwal","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109386","article-title":"TNF-\u03b1-induced alterations in stromal progenitors enhance leukemic stem cell growth via CXCR2 signaling","volume":"36","author":"Agarwal","year":"2021","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2016-05-714089","article-title":"Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI","volume":"129","author":"Agarwal","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib7","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.18632\/oncotarget.7370","article-title":"Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion","volume":"7","author":"Alonso","year":"2016","journal-title":"Oncotarget"},{"issue":"49","key":"10.1016\/j.critrevonc.2025.105090_bib8","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","article-title":"Mesenchymal stromal cells as cancer promoters","volume":"43","author":"Antoon","year":"2024","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41375-025-02664-w","article-title":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"39","author":"Apperley","year":"2025","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105090_bib10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/sctm.17-0175","article-title":"Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment","volume":"7","author":"Arrigoni","year":"2018","journal-title":"Stem Cells Transl. Med"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.105090_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246141","article-title":"Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update","volume":"20","author":"Bavaro","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib13","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-13-0410","article-title":"Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo","volume":"13","author":"Beider","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib14","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1158\/1078-0432.CCR-16-1930","article-title":"Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia","volume":"23","author":"Ben-Batalla","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.105090_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111067","article-title":"Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs","volume":"116","author":"Benjamin","year":"2024","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib16","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V85.12.3636.bloodjournal85123636","article-title":"Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages","volume":"85","author":"Bhatia","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.105090_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fonc.2018.00194","article-title":"Residual Peripheral Blood CD26","volume":"8","author":"Bocchia","year":"2018","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","article-title":"Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment","volume":"26","author":"Bosc","year":"2017","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41375-018-0175-0","article-title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","volume":"32","author":"Br\u00fcck","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib21","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1038\/sj.leu.2404917","article-title":"Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia","volume":"21","author":"Buesche","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.20380","article-title":"Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia","volume":"101","author":"Bueso-Ramos","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.105090_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcell.2019.00136","article-title":"Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML","volume":"7","author":"Bugler","year":"2019","journal-title":"Front Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib24","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"Burger","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12964-023-01363-2","article-title":"Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach","volume":"21","author":"Busch","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092072","article-title":"Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?","volume":"14","author":"Busek","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6960","key":"10.1016\/j.critrevonc.2025.105090_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib28","article-title":"IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia","volume":"13","author":"Cambria","year":"2023","journal-title":"Life (Basel)"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2741\/4901","article-title":"Crosstalk between CML cells with HUVECS and BMSCs through CML derived exosomes","volume":"26","author":"Cetin","year":"2021","journal-title":"Front Biosci. (Landmark Ed."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib30","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.7150\/thno.83178","article-title":"BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution","volume":"13","author":"Chai","year":"2023","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.105090_bib31","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2003-02-0562","article-title":"Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells","volume":"102","author":"Chandra","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib32","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3324\/haematol.2009.008631","article-title":"ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug","volume":"94","author":"Chapuy","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib33","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S2352-3026(19)30094-8","article-title":"De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial","volume":"6","author":"Clark","year":"2019","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-023-02273-z","article-title":"Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial","volume":"29","author":"Crees","year":"2023","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib39","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41467-024-45471-0","article-title":"Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche","volume":"15","author":"Dawson","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"issue":"5894","key":"10.1016\/j.critrevonc.2025.105090_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.105090_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1473139","article-title":"The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy","volume":"15","author":"Decroos","year":"2024","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib44","first-page":"73","article-title":"Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option","volume":"142","author":"Dolinska","year":"2023","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.105090_bib45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib46","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.3324\/haematol.2022.280811","article-title":"Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial","volume":"107","author":"Dulucq","year":"2022","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105090_bib47","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16\u201360 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm","volume":"20","author":"D\u00f6hner","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/leu.2016.179","article-title":"The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment","volume":"31","author":"Eadie","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccell.2019.08.004","article-title":"Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants","volume":"36","author":"Eide","year":"2019","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib50","doi-asserted-by":"crossref","first-page":"15288","DOI":"10.1002\/jcb.28796","article-title":"Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia","volume":"120","author":"El-Khazragy","year":"2019","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.21908","article-title":"The hematopoietic stem cell niche: low in oxygen but a nice place to be","volume":"222","author":"Eliasson","year":"2010","journal-title":"J. Cell Physiol."},{"issue":"34","key":"10.1016\/j.critrevonc.2025.105090_bib52","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","article-title":"A small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]","volume":"101","author":"Emami","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","article-title":"Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures","volume":"22","author":"Feng","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib54","first-page":"6042","article-title":"PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia","volume":"11","author":"Filik","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib55","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.bbrc.2005.05.203","article-title":"Osteopontin is upregulated by BCR-ABL","volume":"333","author":"Flamant","year":"2005","journal-title":"Biochem Biophys. Res Commun."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib56","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3109\/10428194.2012.696313","article-title":"Chronic myeloid leukemia stem cells display alterations in expression of genes involved in oxidative phosphorylation","volume":"53","author":"Flis","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib57","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib58","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","article-title":"JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo","volume":"124","author":"Gallipoli","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158392","article-title":"Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients","volume":"11","author":"Giallongo","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/biom13121701","article-title":"Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers","volume":"13","author":"Giallongo","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib61","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/leu.2014.38","article-title":"The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia","volume":"28","author":"Giannoudis","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib62","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia","volume":"23","author":"Giustacchini","year":"2017","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2018.212365","article-title":"The vascular bone marrow niche influences outcome in chronic myeloid leukemia","volume":"105","author":"Godavarthy","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1590\/1414-431x20153646","article-title":"Circulating endothelial cells are increased in chronic myeloid leukemia blast crisis","volume":"48","author":"Godoy","year":"2015","journal-title":"Braz. J. Med Biol. Res"},{"issue":"26","key":"10.1016\/j.critrevonc.2025.105090_bib65","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood-2017-08-801019","article-title":"Immature CML cells implement a BMP autocrine loop to escape TKI treatment","volume":"130","author":"Grockowiak","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-025-00608-9","article-title":"CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells","volume":"14","author":"Guoyun","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib67","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/jpet.103.055574","article-title":"Interaction of imatinib mesilate with human P-glycoprotein","volume":"307","author":"Hamada","year":"2003","journal-title":"J. Pharm. Exp. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97371-8","article-title":"Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients","volume":"11","author":"Harada","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib70","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/bjh.18302","article-title":"Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype","volume":"198","author":"Harrington","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib71","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1476-5381.2009.00383.x","article-title":"Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties","volume":"158","author":"Hegedus","year":"2009","journal-title":"Br. J. Pharm."},{"issue":"6022","key":"10.1016\/j.critrevonc.2025.105090_bib72","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/315758a0","article-title":"Structural organization of the bcr gene and its role in the Ph' translocation","volume":"315","author":"Heisterkamp","year":"1985","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.critrevonc.2025.105090_bib73","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12885-019-5871-2","article-title":"Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia","volume":"19","author":"Herrmann","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1189\/jlb.1104655","article-title":"Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK","volume":"78","author":"Hickey","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib76","article-title":"The Critical Role of Adipocytes in Leukemia","volume":"14","author":"Higos","year":"2025","journal-title":"Biol. (Basel)"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib77","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.stem.2018.07.003","article-title":"Distinct Bone Marrow Sources of Pleiotrophin Control Hematopoietic Stem Cell Maintenance and Regeneration","volume":"23","author":"Himburg","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"5-6","key":"10.1016\/j.critrevonc.2025.105090_bib78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/10428190009148392","article-title":"Leptin receptor and leukemia","volume":"36","author":"Hino","year":"2000","journal-title":"Leuk. Lymphoma"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib79","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41588-023-01528-2","article-title":"Cellular plasticity of the bone marrow niche promotes hematopoietic stem cell regeneration","volume":"55","author":"Hirakawa","year":"2023","journal-title":"Nat. Genet"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061311","article-title":"Targeting Chronic Myeloid Leukemia Stem\/Progenitor Cells Using Venetoclax-Loaded Immunoliposome","volume":"13","author":"Houshmand","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib81","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib82","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"issue":"7264","key":"10.1016\/j.critrevonc.2025.105090_bib83","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","article-title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling","volume":"461","author":"Huang","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bjh.12246","article-title":"Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistance","volume":"161","author":"Hupfeld","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib85","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41375-023-02074-w","article-title":"Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation","volume":"38","author":"Huuhtanen","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib86","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1186\/s12885-023-11623-6","article-title":"Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment","volume":"23","author":"H\u00e4selbarth","year":"2023","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib87","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/bloodadvances.2022008854","article-title":"Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia","volume":"7","author":"Irani","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2025.105090_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep25476","article-title":"Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia","volume":"6","author":"Irvine","year":"2016","journal-title":"Sci. Rep."},{"issue":"7599","key":"10.1016\/j.critrevonc.2025.105090_bib89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib90","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI8257","article-title":"A role for heterologous gap junctions between melanoma and endothelial cells in metastasis","volume":"105","author":"Ito","year":"2000","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib91","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105090_bib92","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance","volume":"123","author":"Jacamo","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib93","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/jcp.27142","article-title":"Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes","volume":"234","author":"Jafarzadeh","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib94","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3324\/haematol.2019.232793","article-title":"The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission","volume":"106","author":"Jeanpierre","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib97","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Jiang","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","article-title":"CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells","volume":"7","author":"Jin","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib99","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190787","article-title":"Deregulated Notch and Wnt signaling activates early-stage myeloid regeneration pathways in leukemia","volume":"217","author":"Kang","year":"2020","journal-title":"J. Exp. Med"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.105090_bib100","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib101","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-12-1777","article-title":"Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia","volume":"19","author":"Katagiri","year":"2013","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib102","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"issue":"751","key":"10.1016\/j.critrevonc.2025.105090_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi5336","article-title":"Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia","volume":"16","author":"Khalaf","year":"2024","journal-title":"Sci. Transl. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib104","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5045\/kjh.2011.46.4.244","article-title":"Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro","volume":"46","author":"Kim","year":"2011","journal-title":"Korean J. Hematol."},{"key":"10.1016\/j.critrevonc.2025.105090_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114658","article-title":"CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cells","volume":"190","author":"Kim","year":"2021","journal-title":"Biochem Pharm."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2025.105090_bib107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/10428199509059613","article-title":"Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia","volume":"18","author":"Kimura","year":"1995","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib108","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3324\/haematol.10955","article-title":"Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide (Trisenox) through glutathione-depletion in imatinib-resistant cells","volume":"92","author":"Konig","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020843","article-title":"The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.leu.2402769","article-title":"Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study","volume":"17","author":"Korkolopoulou","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.105090_bib111","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semcancer.2017.07.006","article-title":"Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options","volume":"51","author":"Koschmieder","year":"2018","journal-title":"Semin Cancer Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib112","first-page":"471","article-title":"[Angiogenesis in different clinical phases of chronic myeloid leukemia]","volume":"66","author":"Krasowska-Kwiecie\u0144","year":"2009","journal-title":"Przegl Lek."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib113","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat. Med"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.105090_bib114","first-page":"2738","article-title":"A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia","volume":"141","author":"Krishnan","year":"2023","journal-title":"Blood"},{"issue":"7473","key":"10.1016\/j.critrevonc.2025.105090_bib115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105090_bib116","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med"},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105090_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011093","article-title":"Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid Leukemia","volume":"25","author":"Kusaba","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib119","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3324\/haematol.2017.169946","article-title":"CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting","volume":"103","author":"Landberg","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jmcb\/mjz090","article-title":"Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors","volume":"12","author":"Le Naour","year":"2020","journal-title":"J. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib121","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3324\/haematol.2018.197004","article-title":"Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis","volume":"103","author":"Le","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib122","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CM9.0000000000002554","article-title":"Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication","volume":"136","author":"Li","year":"2023","journal-title":"Chin. Med J. (Engl. )"},{"issue":"50","key":"10.1016\/j.critrevonc.2025.105090_bib123","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105090_bib124","doi-asserted-by":"crossref","first-page":"25055","DOI":"10.18632\/aging.203779","article-title":"IGFBP-6\/sonic hedgehog\/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis","volume":"13","author":"Longhitano","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2025.105090_bib125","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fonc.2019.00939","article-title":"BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia","volume":"9","author":"Loscocco","year":"2019","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib126","first-page":"FC04","article-title":"Does CD34 Staining Reflect the Angiogenic Process in the Bone Marrow? An Analysis of a Series of Chronic Myeloid Leukemia Patients","volume":"8","author":"Mahadevan","year":"2014","journal-title":"J. Clin. Diagn. Res"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.105090_bib127","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1200\/JCO.23.01647","article-title":"European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission","volume":"42","author":"Mahon","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12935-025-03805-y","article-title":"BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake","volume":"25","author":"Mancini","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2217\/rme-2016-0121","article-title":"The bone marrow pericyte: an orchestrator of vascular niche","volume":"11","author":"Mangialardi","year":"2016","journal-title":"Regen. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-018-0805-1","article-title":"Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia","volume":"17","author":"Massimino","year":"2018","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105090_bib132","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.it.2011.06.011","article-title":"Hematopoietic stem and progenitor cell trafficking","volume":"32","author":"Mazo","year":"2011","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib133","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/cas.13285","article-title":"Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies","volume":"108","author":"Minami","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","article-title":"Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion","volume":"15","author":"Mineo","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.critrevonc.2025.105090_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111632","article-title":"Some new aspects of erastin-induced ferroptosis in cancer cells","volume":"419","author":"Mlejnek","year":"2025","journal-title":"Chem. Biol. Inter."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib136","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib137","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib138","first-page":"455","article-title":"Carbenoxolone induces apoptosis and inhibits survivin and survivin-\u0394Ex3 genes expression in human leukemia K562 cells","volume":"19","author":"Moosavi","year":"2011","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib139","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","article-title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","volume":"128","author":"Moschoi","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"7308","key":"10.1016\/j.critrevonc.2025.105090_bib141","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-Ferrer","year":"2010","journal-title":"Nature"},{"issue":"7281","key":"10.1016\/j.critrevonc.2025.105090_bib142","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib143","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cas.12849","article-title":"Novel oral transforming growth factor-\u03b2 signaling inhibitor EW-7197 eradicates CML-initiating cells","volume":"107","author":"Naka","year":"2016","journal-title":"Cancer Sci."},{"issue":"7252","key":"10.1016\/j.critrevonc.2025.105090_bib144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.105090_bib145","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.105090_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.637675","article-title":"The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment","volume":"9","author":"Ni","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib147","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/acs.jproteome.9b00028","article-title":"Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival","volume":"18","author":"Noel","year":"2019","journal-title":"J. Proteome Res"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib148","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib149","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2006-04-016600","article-title":"Hematopoietic origin of fibroblasts\/myofibroblasts: Its pathophysiologic implications","volume":"108","author":"Ogawa","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.105090_bib150","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11899-023-00688-6","article-title":"The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities","volume":"18","author":"Patterson","year":"2023","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib152","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.clml.2023.12.015","article-title":"Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia","volume":"24","author":"Pepeler","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.105090_bib153","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1038\/sj.onc.1207543","article-title":"Translational regulation by the p210 BCR\/ABL oncoprotein","volume":"23","author":"Perrotti","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib154","article-title":"Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism","volume":"16","author":"Peterson","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105090_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121526","article-title":"Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies","volume":"8","author":"Petty","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib156","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood.V88.6.2279.bloodjournal8862279","article-title":"CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis","volume":"88","author":"Pierson","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib157","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1042","article-title":"Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture","volume":"7","author":"Pollmann","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib158","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2008-10-184721","article-title":"BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells","volume":"114","author":"Ramirez","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib159","first-page":"294","article-title":"Flow Cytometry Assessment of CD26. Cytometry B Clin Cytom","volume":"96","author":"Raspadori","year":"2019"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib160","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2025.105090_bib161","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.2147\/IJN.S215711","article-title":"Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles","volume":"14","author":"Roma-Rodrigues","year":"2019","journal-title":"Int J. Nanomed."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib162","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood.V108.11.4777.4777","article-title":"Imatinib 400 mg in Early Chronic Phase CML: Results of a Multicentric, Prospective Non Academical Observational Study (by the GIMEMA CML Working Party)","volume":"108","author":"Rosti","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib163","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.stem.2020.04.005","article-title":"Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors","volume":"27","author":"Rothe","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"5405","key":"10.1016\/j.critrevonc.2025.105090_bib164","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1634\/stemcells.22-4-457","article-title":"BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor","volume":"22","author":"Sadlon","year":"2004","journal-title":"Stem Cells"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.105090_bib166","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib167","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib168","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.critrevonc.2025.105090_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576559","article-title":"P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers","volume":"10","author":"Seelig","year":"2020","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib170","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/bloodadvances.2018027516","article-title":"Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI","volume":"3","author":"Shanmuganathan","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib171","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bcmd.2014.07.012","article-title":"The effects of Gremlin1 on human umbilical cord blood hematopoietic progenitors","volume":"54","author":"Shekels","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib172","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.leukres.2010.09.019","article-title":"Chronic myelogenous leukemia cells convert to myofibroblasts in vitro: effect of vascular endothelial growth factor on development of the microenvironment","volume":"35","author":"Shirasaki","year":"2011","journal-title":"Leuk. Res"},{"issue":"72","key":"10.1016\/j.critrevonc.2025.105090_bib173","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.critrevonc.2025.105090_bib174","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8086398","article-title":"Assessment of the number and phenotype of macrophages in the human BMB samples of CML","volume":"2016","author":"Song","year":"2016","journal-title":"Biomed. Res Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/07357907.2017.1422512","article-title":"Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK\/ERK and PI3K\/AKT and the Wnt\/\u03b2-Catenin Pathways","volume":"36","author":"Song","year":"2018","journal-title":"Cancer Invest"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib176","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/hematology.2023000447","article-title":"Resistance mutations in CML and how we approach them","volume":"2023","author":"Soverini","year":"2023","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.leukres.2013.09.011","article-title":"Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia","volume":"38","author":"Soverini","year":"2014","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib178","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4155\/fmc-2019-0350","article-title":"The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance","volume":"12","author":"Stefan","year":"2020","journal-title":"Future Med Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib179","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.leu.2404692","article-title":"ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?","volume":"21","author":"Steinbach","year":"2007","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib180","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.20041992","article-title":"Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size","volume":"201","author":"Stier","year":"2005","journal-title":"J. Exp. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib181","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2025.105090_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116763","article-title":"Cotargeting of thioredoxin 1 and glutamate-cysteine ligase in both imatinib-sensitive and imatinib-resistant CML cells","volume":"233","author":"Sun","year":"2025","journal-title":"Biochem Pharm."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105090_bib183","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/s41423-020-0487-7","article-title":"PD-L1+ exosomes from bone marrow-derived cells of tumor-bearing mice inhibit antitumor immunity","volume":"18","author":"Sun","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105090_bib184","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.4246","article-title":"The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia","volume":"231","author":"Suresh","year":"2013","journal-title":"J. Pathol."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105090_bib185","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/1873-3468.13967","article-title":"An inventory of lysosomal ABC transporters","volume":"594","author":"Szakacs","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.critrevonc.2025.105090_bib186","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2016.11.006","article-title":"Pericytes, integral components of adult hematopoietic stem cell niches","volume":"171","author":"S\u00e1 da Bandeira","year":"2017","journal-title":"Pharm. Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib187","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bjh.18355","article-title":"Diversity in the bone marrow niche: Classic and novel strategies to uncover niche composition","volume":"199","author":"S\u00e1nchez-Lanzas","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib188","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41467-021-27928-8","article-title":"Eliminating chronic myeloid leukemia stem cells by IRAK1\/4 inhibitors","volume":"13","author":"Tanaka","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.105090_bib189","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-4598-13-169","article-title":"Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells","volume":"13","author":"Taverna","year":"2014","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib190","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/ijc.26217","article-title":"Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis","volume":"130","author":"Taverna","year":"2012","journal-title":"Int J. Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2025.105090_bib191","doi-asserted-by":"crossref","first-page":"28160","DOI":"10.18632\/oncotarget.8583","article-title":"Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis","volume":"7","author":"Thuringer","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib192","article-title":"Bone marrow adiposity and the hematopoietic niche: a historical perspective of reciprocity, heterogeneity, and lineage commitment","volume":"35","author":"Tratwal","year":"2021","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105090_bib193","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5483\/BMBRep.2022-0095","article-title":"Hypoxia-inducible factor 1\u03b1 inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells","volume":"56","author":"Tsubaki","year":"2023","journal-title":"BMB Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112535","article-title":"Transporter-mediated cellular distribution of tyrosine kinase inhibitors as a potential resistance mechanism in chronic myeloid leukemia","volume":"15","author":"Verhagen","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105090_bib195","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2009.017178","article-title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4\/CXCL12 axis","volume":"95","author":"Vianello","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib196","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s43018-025-00933-2","article-title":"A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib197","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3748\/wjg.v17.i5.625","article-title":"Influence of CXCR4\/SDF-1 axis on E-cadherin\/\u03b2-catenin complex expression in HT29 colon cancer cells","volume":"17","author":"Wang","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.105090_bib198","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.2147\/OTT.S249425","article-title":"The CXCR4 antagonist, AMD3100, reverses mesenchymal stem cell-mediated drug resistance in relapsed\/refractory acute lymphoblastic leukemia","volume":"13","author":"Wang","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.critrevonc.2025.105090_bib199","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92074.3","article-title":"Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response","volume":"12","author":"Warfvinge","year":"2024","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib200","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Weisberg","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib201","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ccell.2015.04.004","article-title":"Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells","volume":"27","author":"Welner","year":"2015","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105090_bib202","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: State of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib203","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat. Med"},{"issue":"7647","key":"10.1016\/j.critrevonc.2025.105090_bib204","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2159-8290.CD-15-1439","article-title":"Chronic myelogenous leukemia- initiating cells require polycomb group protein EZH2","volume":"6","author":"Xie","year":"2016","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib206","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41419-022-04842-5","article-title":"Mitochondrial oxidative phosphorylation is dispensable for survival of CD34","volume":"13","author":"Yan","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib208","article-title":"The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents","volume":"2","author":"Yu","year":"2015","journal-title":"Mol. Cell Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105090_bib209","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10517-012-1667-y","article-title":"Antitumor effects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-differentiated glioma","volume":"153","author":"Yusubalieva","year":"2012","journal-title":"Bull. Exp. Biol. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105090_bib210","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10517-014-2603-0","article-title":"Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy","volume":"157","author":"Yusubalieva","year":"2014","journal-title":"Bull. Exp. Biol. Med"},{"issue":"ement 1","key":"10.1016\/j.critrevonc.2025.105090_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2020-137734","volume":"136","author":"Zeidan","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105090_bib212","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-\u03b2-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib213","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"6960","key":"10.1016\/j.critrevonc.2025.105090_bib214","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.critrevonc.2025.105090_bib215","doi-asserted-by":"crossref","first-page":"12167","DOI":"10.1074\/jbc.RA119.008037","article-title":"Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7\/JAK1\/STAT5 pathway","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105090_bib216","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3324\/haematol.2018.205856","article-title":"Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis","volume":"104","author":"Zhang","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105090_bib217","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"issue":"7239","key":"10.1016\/j.critrevonc.2025.105090_bib218","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.105090_bib219","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fimmu.2014.00352","article-title":"Toll-like receptors and prostate cancer","volume":"5","author":"Zhao","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.105090_bib220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","article-title":"Lysosomes as mediators of drug resistance in cancer","volume":"24","author":"Zhitomirsky","year":"2016","journal-title":"Drug Resist Updat"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105090_bib221","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/leu.2017.87","article-title":"Combined inhibition of \u03b2-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo","volume":"31","author":"Zhou","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105090_bib222","article-title":"Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow microenvironment of chronic myeloid leukemia","volume":"12","author":"Zhuo","year":"2025","journal-title":"Genes Dis."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105090_bib223","doi-asserted-by":"crossref","DOI":"10.3390\/cells14110814","article-title":"Bone marrow niche aging: are adipocytes detrimental cells in the bone marrow?","volume":"14","author":"\u0160vajger","year":"2025","journal-title":"Cells"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:38:03Z","timestamp":1778794683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825004780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":223,"alternative-id":["S1040842825004780"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105090","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the bone marrow microenvironment in leukemic stem cell resistance: Pathways of persistence and selection","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105090"}}